losartan potassium (+) hydrochlorothiazide

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC, Organon and Co

Conditions

HypertensionMetabolic Disorder

Phase 3

Hyzaar Asia HEAALTH (0954A-950)

CompletedNCT00354991

Merck Sharp & Dohme LLCHypertension

Start: 2006-06-01End: 2007-04-01Updated: 2017-05-09

Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

CompletedNCT00398541

Organon and CoHypertension

Start: 2005-03-01End: 2007-06-01Updated: 2024-08-15

A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

CompletedNCT00546052

Organon and CoHypertension, Metabolic Disorder

Start: 2005-09-01End: 2008-01-01Updated: 2024-05-16

BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)

CompletedNCT00546754

Organon and CoHypertension

Start: 2007-05-01End: 2009-05-01Updated: 2024-05-16